The Economist

Advertisment

Big pharma can’t get enough of one class of cancer drugs

Listen to this story. Enjoy more audio and podcasts on iOS or Android.Your browser does not support the element.AROUND THE world, dealmaking is in a rut. A combination of higher interest...

Friendships in the office

Listen to this story. Enjoy more audio and podcasts on iOS or Android.Your browser does not support the element.Scholars of happiness have found that close relationships are one of the critical...

California cracks down on carbon

Listen to this story. Enjoy more audio and podcasts on iOS or Android.Your browser does not support the element.Climate Week NYC got off to an early start in California. In the...

What Arm and Instacart say about the coming IPO wave

Listen to this story. Enjoy more audio and podcasts on iOS or Android.Your browser does not support the element.Tech bosses have long sought to disrupt the initial public offering (IPO). They...

America’s big car firms face lengthy strikes

The car industry faces unprecedented upheaval as the importance of the internal-combustion engine, which has defined it for more than a century, declines and that of battery power, which will define its...

Could OpenAI be the next tech giant?

The creation of a new market is like the start of a long race. Competitors jockey for position as spectators excitedly clamour. Then, like races, markets enter a calmer second phase. The...

Arm’s successful debut may signal an end to the IPO drought

Pop! Few events in financial markets this year were as hotly anticipated as the listing on September 14th of Arm, a British chipmaker whose designs are found in nearly every smartphone. The...

Who is the most important person in your company?

Questions are usually more interesting than answers. If you had to identify the most important person in your organisation, there is an obvious answer, a trite-and-untrue answer and a wrong-but-useful answer.The obvious...

The Economist

Advertisment